| Novel heart failure drug shows great promise. |
|
| Reuters: LCZ696 is a two-in-one pill, taken twice a day, combining Diovan's active ingredient valsartan and another class of drug called a neprilysin inhibitor. In terms of side effects, patients on LCZ696 suffered more low blood pressure and non-serious swelling but less kidney impairment, high potassium and cough than the enalapril group. |